MPLT
Financials
- Market Capitalization 1.64 B
- Employee 133
- Founded 2018
- CEO N/A
- Website www.maplightrx.com
- Headquarter Delaware, United States
- FIGI BBG01JZ5DBQ0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2125 |  FTRE Fortrea Holdings Inc. - Common Stock | 17.60 USD | -2.38% | +4.76% | +5.58% | +268.97% | 1.66 B USD | ||
| 2128 |  GHRS GH Research PLC - Ordinary Shares | 26.46 USD | -1.16% | +0.61% | +30.60% | +86.86% | 1.64 B USD | ||
| 2138 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.93 USD | +4.04% | -5.72% | -1.17% | +135.32% | 1.70 B USD | ||
| 2142 |  ANAB AnaptysBio, Inc. - Common Stock | 56.57 USD | -9.50% | -12.85% | -5.72% | +60.71% | 1.65 B USD |
Frequently asked questions about MapLight Therapeutics, Inc. - Common Stock
What is the MapLight Therapeutics, Inc. - Common Stock stock price today?
The current price of MapLight Therapeutics, Inc. - Common Stock (MPLT) is 36.22. Over the past 24 hours, the stock has changed by -4.46%. Follow the MPLT chart for real-time price dynamics.
What is the stock ticker of MapLight Therapeutics, Inc. - Common Stock?
MapLight Therapeutics, Inc. - Common Stock trades under the ticker MPLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MapLight Therapeutics, Inc. - Common Stock stock going up?
MPLT has changed by -1.42% over the last week, +29.50% over the last month, and +90.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MapLight Therapeutics, Inc. - Common Stock net income for the last quarter?
MapLight Therapeutics, Inc. - Common Stock reported net income of -60.67 M for the last quarter. The previous quarter showed -79.55 M, which means net income changed by +23.73%.
How many employees does MapLight Therapeutics, Inc. - Common Stock have?
As of the latest available data, MapLight Therapeutics, Inc. - Common Stock has 133 employees. Workforce size can provide additional context about the company's scale and operations.
What is MapLight Therapeutics, Inc. - Common Stock EBITDA?
MapLight Therapeutics, Inc. - Common Stock EBITDA is -65.16 M, and its EBITDA margin is 1.63 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MapLight Therapeutics, Inc. - Common Stock stock?
You can buy MapLight Therapeutics, Inc. - Common Stock (MPLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MapLight Therapeutics, Inc. - Common Stock stock?
Investing in MapLight Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MPLT chart and related analysis on metatrader.com as part of your research.